Arthritis Foundation

OneCause Celebrates 15 Years of Innovation and $6.5 Billion Raised by Nonprofits

Retrieved on: 
Thursday, February 15, 2024
Human Rights Campaign, Platform, The Platform, Organization, Arthritis Foundation, Partnership

INDIANAPOLIS, Feb. 15, 2024 /PRNewswire/ -- OneCause, a leading provider of digital fundraising technology, wrapped its fifteenth year and entered 2024 celebrating a major milestone. Since the company's founding, its nonprofit customers have collectively raised over $6.5 billion for their causes using OneCause fundraising software. In 2023 alone, OneCause customers raised $1.4 billion.

Key Points: 
  • INDIANAPOLIS, Feb. 15, 2024 /PRNewswire/ -- OneCause , a leading provider of digital fundraising technology, wrapped its fifteenth year and entered 2024 celebrating a major milestone.
  • Since the company's founding, its nonprofit customers have collectively raised over $6.5 billion for their causes using OneCause fundraising software.
  • In 2023 alone, OneCause customers raised $1.4 billion.
  • Through these initiatives, OneCause strives to revolutionize giving for nonprofits and donors alike.

AbelZeta Announces Formation of Scientific Advisory Board to Support Inflammatory and Immunological Diseases

Retrieved on: 
Wednesday, January 3, 2024
Arthritis, Quality of life, University, Canadian Aviation Regulations, Honorary, CD20, SLE, SAB, Society, Innovation, Cancer, Autoimmune disease, UCSF, Skin condition, Hospital for Special Surgery, B cell, Weill Cornell Medicine, Safety, Journal, Lupus nephritis, Human musculoskeletal system, Biomarker, Arthritis Foundation, Intramural sports, Patient, Hospital, Preventive healthcare, Division, Research, Jean, BCMA, Postgraduate education, Catholic League (German), Rheumatoid arthritis, Lupus Research Alliance, Conditional sentence, Bangladesh Technical Education Board, American College, Cell, CD19, Lee, Culture, Pharmaceutical industry

These four industry experts are distinguished scientific leaders with vast experience in the autoimmune disease field."

Key Points: 
  • These four industry experts are distinguished scientific leaders with vast experience in the autoimmune disease field."
  • Members of the SAB include:
    Peter Lipsky, M.D., served on the Board of Directors of the American College of Rheumatology.
  • She was President of the American College of Rheumatology, President of the Henry Kunkel Society, and Chair of the Scientific Advisory Board of the Lupus Research Alliance.
  • "AbelZeta is advancing promising new therapies for inflammatory and immunological diseases through innovative cell therapy platforms that provide custom-tailored treatment for each individual patient.

Peachtree Group Appoints Sameer Nair as Senior Vice President of Equity Asset Management

Retrieved on: 
Tuesday, December 19, 2023
Commercial Building & Real Estate, Construction & Property, REIT, Arthritis, Multimedia, Urban Land Institute, Acquisition, Cornell University, Investment, Growth, Arthritis Foundation, Financial services

Peachtree Group, a diversified commercial real estate investment firm, has named Sameer Nair as senior vice president of equity asset management.

Key Points: 
  • Peachtree Group, a diversified commercial real estate investment firm, has named Sameer Nair as senior vice president of equity asset management.
  • In this role, he will oversee and implement asset oversight to Peachtree’s real estate portfolio and preferred equity investments.
  • View the full release here: https://www.businesswire.com/news/home/20231219362690/en/
    Peachtree Group, a diversified commercial real estate investment firm, has named Sameer Nair (pictured) as senior vice president of equity asset management.
  • (Photo: Business Wire)
    As an experienced asset manager with development and transactional experience, Nair brings unique experiences and capabilities to the firm.

The Inner Circle Acknowledges, Thomas P. Olenginski, MD, FACP as a Pinnacle Lifetime Member for his contributions to the field of Rheumatology

Retrieved on: 
Monday, October 16, 2023
Certification, United Methodist Church, Geisinger, Internal medicine, Fellow, International Society, Osteoporosis, School, American College, Bachelor of Science in Nursing, South Central Pennsylvania, Society, Arthritis Foundation, International Society for Clinical Densitometry, Fracture, Rheumatoid arthritis, Arthritis, Geisinger Commonwealth School of Medicine, FACP, Medical school, Pennsylvania State University, American College of Rheumatology, American College of Physicians, Relaxation, Athlete, Inner circle, Patient, Quality of life, Nursing, MD, Rheumatology, Medicine, Physician

LEWISBURG, Pa., Oct. 16, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Thomas P. Olenginski, MD, FACP is acknowledged as a Pinnacle Lifetime Member for his contributions to the field of Rheumatology.

Key Points: 
  • LEWISBURG, Pa., Oct. 16, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Thomas P. Olenginski, MD, FACP is acknowledged as a Pinnacle Lifetime Member for his contributions to the field of Rheumatology.
  • Dr. Olenginski pursued his pre-medical studies at Pennsylvania State University where he earned a Bachelor of Science degree.
  • The doctor has many roles at Geisinger Commonwealth School of Medicine, including teaching fellows in rheumatology and medical students with a focus on osteoporosis.
  • He actively participates in St. Paul's United Methodist Church, where he is a valued member, embodying his commitment to his faith and community involvement.

AOFAS Annual Meeting 2023 Highlights Orthopaedic Research and Innovation

Retrieved on: 
Thursday, September 28, 2023
Ankle, Society, American Orthopaedic Foot and Ankle Society, Arthritis Foundation, Proceedings of the Human Factors and Ergonomics Society Annual Meeting, Foot, Arthritis, MBA, Research, Achilles tendon, Doctor of Philosophy, Monte Carlo method, Annual general meeting, MBE, Bunion, Patient, AF, Health, Treatment, Female, Nursing, Pharmaceutical industry, Dentistry, MD

ROSEMONT, Ill., Sept. 28, 2023 (GLOBE NEWSWIRE) -- More than 900 foot and ankle orthopaedic surgeons, advanced health practitioners, orthopaedic residents, and medical students attended the American Orthopaedic Foot & Ankle Society® (AOFAS) Annual Meeting on September 20-23, 2023.

Key Points: 
  • ROSEMONT, Ill., Sept. 28, 2023 (GLOBE NEWSWIRE) -- More than 900 foot and ankle orthopaedic surgeons, advanced health practitioners, orthopaedic residents, and medical students attended the American Orthopaedic Foot & Ankle Society® (AOFAS) Annual Meeting on September 20-23, 2023.
  • The meeting offered attendees 181 live presentations, 40 e-podium presentations, 300 poster presentations, and the opportunity to connect with 81 exhibiting companies.
  • Also at the Annual Meeting, AOFAS and the Arthritis Foundation (AF) announced the recipients of the first ever AF/AOFAS Ankle Arthritis Thank Tank Research Grants.
  • On the third day of the meeting, orthopaedic foot and ankle surgeon, Michael S. Aronow, MD, of Hartford, Connecticut, was installed as the 2023-24 president of the AOFAS Board of Directors.

Annual Cycling Event in California Raises Over $1 Million to Fight Arthritis, Impacting Nearly 60 Million Adults and Hundreds of Thousands of Children in the U.S.

Retrieved on: 
Wednesday, September 27, 2023
Volunteering, Amgen, Arthritis, Partnership, Education, Friends, Disability, Arthritis Foundation, Quality of life, Outside (magazine), Research, Kate, Science, CCC, Patient, Nonsteroidal anti-inflammatory drug, Autoimmune disease, Ibuprofen, Family, National Senior Classical League, Fatigue, Amusement park, Pharmaceutical industry, Tourism, California Coast Classic Bike Tour

Two hundred cyclists will embark on the eight-day, 525-mile tour while raising funds and awareness for the Arthritis Foundation and the nearly 60 million U.S. adults with arthritis.

Key Points: 
  • Two hundred cyclists will embark on the eight-day, 525-mile tour while raising funds and awareness for the Arthritis Foundation and the nearly 60 million U.S. adults with arthritis.
  • This year, at least 80 of the approximately 200 riders have identified themselves as living with arthritis.
  • It’s the number one cause of disability and a growing health crisis affecting nearly 60 million adults and hundreds of thousands of children in the U.S.
  • Since 1948, the Arthritis Foundation has invested over half a billion dollars in research, with more than $22 million coming directly from the California Coast Classic.

AOFAS and the Arthritis Foundation Award Grants to Fuel Ankle Arthritis Research

Retrieved on: 
Tuesday, September 19, 2023
Ankle, Osteoarthritis, Duke University, University, American Orthopaedic Foot and Ankle Society, Arthritis, Arthritis Foundation, University of Iowa, Research, Doctor of Philosophy, University of Colorado Denver, Patient, Hospital for Special Surgery, Hospital, AF, Injury, Disease, Pharmaceutical industry, Nursing, MD

Rosemont, Ill., Sept. 19, 2023 (GLOBE NEWSWIRE) -- The American Orthopaedic Foot & Ankle Society (AOFAS) and the Arthritis Foundation (AF) announced the recipients of the first-ever AF/AOFAS Ankle Arthritis Think Tank Research Grants.

Key Points: 
  • Rosemont, Ill., Sept. 19, 2023 (GLOBE NEWSWIRE) -- The American Orthopaedic Foot & Ankle Society (AOFAS) and the Arthritis Foundation (AF) announced the recipients of the first-ever AF/AOFAS Ankle Arthritis Think Tank Research Grants.
  • The grants provide substantial funding to support innovative clinical research that advances knowledge toward treatments to stop or slow ankle osteoarthritis.
  • This month, AF and AOFAS awarded three grants, each totaling almost $200,000 over a two-year period, to AOFAS members dedicated to furthering their ankle osteoarthritis research.
  • “This award represents a major step forward for our collaborative effort to understand the unique nature of ankle arthritis.

Allsup Employment Services Joins Arthritis Foundation In Presenting Return To Work Webinar For Arthritis Patients On Aug. 26

Retrieved on: 
Tuesday, August 22, 2023
Workforce, Social Security Disability Insurance, Employment, Ontario Disability Employment Network, Arthritis, Q&A, Disability, Arthritis Foundation, TTW, Quality of life, SSDI, Beth Gladen, Patient, Social Security, Korea Disease Control and Prevention Agency, Smiths News, AES, Social, SSA, Health insurance, Nursing, Insurance, Zoom

This free online event will focus on the Social Security Administration’s (SSA) Ticket to Work (TTW) Program, emphasizing its significance for arthritis patients who receive Social Security Disability Insurance (SSDI) benefits.

Key Points: 
  • This free online event will focus on the Social Security Administration’s (SSA) Ticket to Work (TTW) Program, emphasizing its significance for arthritis patients who receive Social Security Disability Insurance (SSDI) benefits.
  • More than 159 million U.S. workers are insured for the SSDI program in the event of a severe disability.
  • Gladen will demystify the Ticket to Work Program, highlight the crucial role of Employment Networks, and detail the comprehensive services provided by AES.
  • “A common misconception about the Ticket To Work Program is that enrollees will instantly forfeit their disability benefits if they attempt to return to work,” Gladen said.

OneCause Introduces Auction AI™ to Boost Nonprofit Fundraising Event Success

Retrieved on: 
Thursday, August 17, 2023
Arthritis Foundation, ChatGPT, Intelligence, Research, Auction, Organization, Acquisition, Artificial intelligence, Growth, AI, ROI, Express, Software, Cryptocurrency, Sales, Management

INDIANAPOLIS, Aug. 17, 2023 /PRNewswire/ -- OneCause, a leading provider of digital fundraising technology, announced the release of Auction AI, an innovative toolset that leverages the power of artificial intelligence to revolutionize giving through donor personalization and choice, increase fundraising revenue, and save nonprofits time during event setup.

Key Points: 
  • OneCause customers can now rely on Auction AI to curate personalized recommendations for auction packages.
  • With Auction AI, nonprofits can effortlessly amplify their fundraising by leveraging data at scale to achieve greater success and impact.
  • OneCause Auction AI tools focus on incorporating experiences that today's supporters are accustomed to from their online shopping experiences.
  • These new Auction AI features will save organizations time, help generate engaging content, and dramatically streamline auction planning.

XBiotech Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial

Retrieved on: 
Tuesday, August 8, 2023
NRS, ACR, APG system, RA, Arthritis, Interleukin-1 family, Enterprise master patient index, Arthritis Foundation, Quality of life, American College of Rheumatology, Tenderness, Inflammation, Person, Rheumatoid arthritis, CDC, Pain, Joint, American College, Phase, CDAI, MTX, Safety, Pharmaceutical industry

AUSTIN, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today began treating the first patient in a phase II, double-blind, placebo-controlled, randomized clinical study to evaluate Natrunix as a new treatment for Arthritis.

Key Points: 
  • AUSTIN, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today began treating the first patient in a phase II, double-blind, placebo-controlled, randomized clinical study to evaluate Natrunix as a new treatment for Arthritis.
  • Natrunix blocks a key cause of inflammation involved in pain and joint destruction in rheumatoid arthritis (RA).
  • The primary endpoint of the Phase II is the American College of Rheumatology (ACR) 20% Response (ACR 20) rate at 12 weeks.
  • In addition, it is expected that 300,000 children will suffer from juvenile arthritis (Arthritis Foundation, 2023).